个人简介
教育经历
2002.09-2006.06,宜春学院药学学士/本科
2007.09-2010.06,温州医科大学中药学硕士/研究生
2013.10-2015.01,美国俄亥俄州立大学肿瘤学联合培养博士生
2011.09-2016.11,南京理工大学生物化工博士/研究生
专家类别
1.温州市551第二层次人才(2014)
研究领域
肿瘤免疫治疗中的药物化学
承担科研项目情况
1.国家自然科学基金,81202462,IL-6/STAT3通路双重抑制剂的发现及抗肿瘤药物设计
2.浙江省自然科学基金,Y4110197,靶向Cys-486的FGFR选择性不可逆抑制剂设计、合成和生物学功能研究
近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1.LeheYang#,ShichongLin#,YantingKang#,YouqunXiang,LingyuanXu,JifaLi,XuanxuanDai,GuangLiang,XiaoyingHuang*,ChengguangZhao*,RheinsensitizeshumanpancreaticcancercellstoEGFRinhibitorsbyinhibitingSTAT3pathway.JExpClinCancerRes.2019,38(1):31.(IF=6.217二区).
2.ChengweiZhao#,WeilanCao#,HailunZheng#,ZhongxiangXiao,JieHu,LeheYang,MinChen,GuangLiang,SuqingZheng*,ChengguangZhao*,Acid-responsivenanoparticlesasanoveloxidativestressinducinganticancertherapeuticagentsforcoloncancer.IntJNanomedicine.2019,14:1597-1618.(IF=4.370二区).
3.HailunZheng#,LeheYang#,YantingKang#,MinChen,ShichongLin,YouqunXiang,CalebLi,XuanxuanDai,XiaoyingHuang*,GuangLiang*,ChengguangZhao*,AlantolactonesensitizeshumanpancreaticcancercellstoEGFRinhibitorsthroughtheinhibitionofSTAT3signaling.MolCarcinog.2019,58(4):565-576.(IF=3.851二区).
4.LeheYang#,JifaLi#,LingyuanXu#,ShichongLin,YouqunXiang,XuanxuanDai,GuangLiang,XiaoyingHuang,JiandongZhu*,ChengguangZhao*,RheinshowsPotentEfficacyagainstNon-Small-CellLungCancerthroughinhibitingSTAT3pathway.CancerManagRes.2019,11:1167-1176.(IF=3.702二区).
5.ChengguangZhao#,HuamengLi#,HueyjenLin,ShulinYang*,JiayuhLin*,GuangLiang,FeedbackActivationofSTAT3asaCancerDrug-ResistanceMechanism,TrendsPharmacolSci.2016,37(1):47-61.(IF=12.108一区)